Fostemsavir

Rukobia 600 mg tabletten met verlengde afgifte

Tablet met verlengde afgifteNetherlandsAuthorisedAuthorised 4 Feb 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

RukobiaEuropean UnionAuthorised

RukobiaCanada · 600 MG · Tablet (Extended-Release) · Viiv Healthcare UlcSame brand
Rukobia 600 MG Comprimidos de Liberacion ProlongadaSpain · 724,56 mg · comprimido de liberación prolongada · Viiv Healthcare B.V.Same brand
RukobiaEuropean Union · ViiV Healthcare B.V.Same brand
RukobiaCroatiaSame brand
RukobiaItaly · Compressa a rilascio prolungato · Viiv Healthcare BVSame brand
RukobiaUnited States · 600MG BASE · tablet, extended release · Viiv HlthcareSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Fostemsavir

Rukobia 600 mg tabletten met verlengde afgifte

Tablet met verlengde afgifteNetherlandsAuthorisedAuthorised 4 Feb 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

RukobiaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Fostemsavir
Dosage form: Tablet met verlengde afgifte
Route: Oraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 4 Feb 2021
Registration: EU/1/20/1518
Marketing authorisation holder: ViiV healthcare B.V.
ATC code: J05AX29
Group: Anti-infectives for systemic use
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/005011
EU number: EU/1/20/1518